Hepatitis C Screening and Treatment | September 11, 2024
Date of Presentation: September 11, 2024
Type: Past Presentation Training
Audience: Clinical
Program: Ending the Epidemics in Indian Country ECHO Program
Keywords: #hcv #hcv screening #hcv treatment #hepatitis c
In this presentation, Brian McMahon, MD and Lisa Townshend-Bulson, RN, MSN, FNP-C from the ANTHC Liver Disease & Hepatitis Program discuss hepatitis C screening and treatment. They cover why screening for hepatitis C is important, how to recognize ways to screen for hepatitis C, how to identify hepatitis C treatment options available, as well as hepatitis C treatment in special populations, how to identify ways to overcome current challenges to hepatitis C cascade and lastly they discuss what it will take to achieve HCV elimination.
Recording:
Presented by:
Brian McMahon, MD
Brian McMahon, MD, is a clinical Liver Specialist (Hepatologist) and the Director of the Liver Disease and Hepatitis Program at the Alaska Native Medical Center in Anchorage, Alaska. He is a guest researcher at the Arctic Investigations Program of the Centers for Disease Control in Anchorage, Auxiliary professor at University of Alaska Health Sciences Program and Clinical Professor of Medicine at the University of Washington.He has directed the vaccination programs in Alaska Natives that have reduced the rates of acute hepatitis A and B from the highest in the US to the lowest in the world. He has been active in research in viral hepatitis A, B, and C, as well as other liver diseases among Alaska Natives/American Indians, for over 35 years. Dr. McMahon is a co-author of the American Association for the Study of Liver Disease (AASLD) US Practice Guideline on Chronic Hepatitis B and co-chair of the WHO hepatitis B Guidelines Committee. He was on the Institute of Medicine Committee that published recommendations for Hepatitis and Liver Cancer in 2010. He is the author or co-author of more than 170 peer-reviewed papers, 50 book chapters, review articles, or editorials.
Lisa Townshend-Bulson, RN, MSN, FNP-C
Lisa Townshend-Bulson, RN, MSN, FNP-C, is the Director of the Alaska Native Tribal Health Consortium (ANTHC) Liver Disease & Hepatitis Program where she practices as a nurse practitioner, is a clinical investigator in liver disease research, and provides program management. She has authored/coauthored several peer-review publications on viral hepatitis. She participates in the American Association for the Study of Liver Diseases (AASLD) Hepatitis B Special Interest Group (SIG), and in the past, participated on the AASLD Public Policy and AASLD Hepatology Associates Committees. Ms. Townshend-Bulson also participated in the Hepatitis C Virus Birth Cohort Testing Work Group for the development of the 2012 CDC guidelines for the screening of baby boomers for hepatitis C. For the past decade, she has been leading efforts in providing continuing education to healthcare providers through the LiverConnect CE program, and more recently for the Liver Disease and AK ID ECHO programs and she leads efforts to maintain up-to-date hepatitis C treatment and other liver disease information for the ANTHC liver disease website www.anthc.org/hep. She holds a Master’s Degree in Nursing/Family Nurse Practitioner and is certified as a Family Nurse Practitioner by the American Association of Nurse Practitioners. She is a member of the American Association for the Study of Liver Diseases and the American Academy of Nurse Practitioners.
Resources Provided:
Date added: August 27, 2024